-+ 0.00%
-+ 0.00%
-+ 0.00%

AMYLYX PHARMACEUTICALS ANNOUNCES PEER-REVIEWED PUBLICATION OF PHASE 2 OPEN-LABEL HELIOS TRIAL DATA FOR AMX0035 IN THE JOURNAL OF CLINICAL INVESTIGATION

Reuters·05/15/2026 16:12:00

Please log in to view news